Xiaoyong Wang | Anticancer drugs | Innovative Research Award

Posted on by Skincare

 

Innovative Research Award

Xiaoyong Wang
Nanjing University

Researcher Information
Affiliation Nanjing University
Country China
Scopus ID 57194713052
Documents 221
Citations 11,435
h-index 53
Subject Area Anticancer Drugs
Event World Skincare Innovation Awards

The Innovative Research Award evaluation recognizes the scholarly achievements and scientific contributions of Xiaoyong Wang of Nanjing University. His publication portfolio demonstrates sustained research productivity, significant citation impact, and notable influence within the field of anticancer drug discovery and related biomedical sciences. With more than two hundred indexed publications and an extensive citation record, his research has contributed to the advancement of therapeutic strategies, translational medicine, and pharmaceutical innovation.[1]

Abstract

This article presents an academic assessment of Xiaoyong Wang in relation to the Innovative Research Award. The evaluation considers publication productivity, citation performance, scholarly influence, and research relevance within the domain of anticancer drug development. Quantitative bibliometric indicators, including publication count, citation volume, and h-index, indicate a sustained and influential research trajectory that aligns with internationally recognized standards of scientific excellence.[1]

Keywords

Anticancer Drugs, Biomedical Research, Drug Discovery, Pharmaceutical Sciences, Translational Medicine, Citation Impact, Research Excellence, Scientific Innovation.

Introduction

Academic recognition programs evaluate researchers based on measurable scientific contributions, influence within their discipline, and the broader significance of their work. Xiaoyong Wang has established a substantial scholarly record through research focused on anticancer therapeutics and related biomedical applications. His work has been disseminated through internationally indexed publications and has attracted considerable scholarly attention, reflecting both relevance and scientific quality.[1][2]

Research Profile

  • Researcher: Xiaoyong Wang
  • Institution: Nanjing University
  • Country: China
  • Scopus Documents: 221
  • Total Citations: 11,435
  • h-index: 53
  • Primary Subject Area: Anticancer Drugs

The available bibliometric indicators demonstrate extensive publication activity combined with a strong citation footprint. Such metrics are frequently used as indicators of scholarly influence, research visibility, and sustained academic engagement within a specialized research field.[1]

Research Contributions

Xiaoyong Wang's research contributions span areas associated with anticancer drug discovery, therapeutic development, molecular mechanisms of disease, and translational biomedical science. His publications have contributed to scientific understanding of emerging therapeutic approaches and have supported ongoing developments in pharmaceutical research.[3]

  • Development of innovative therapeutic strategies.
  • Investigation of molecular targets associated with cancer treatment.
  • Contribution to interdisciplinary biomedical collaborations.
  • Publication of highly cited research articles in peer-reviewed journals.

Publications

The researcher has authored or co-authored 221 indexed documents according to Scopus records. The publication portfolio encompasses original research articles, reviews, and collaborative studies that contribute to the advancement of biomedical and pharmaceutical knowledge. The breadth and consistency of publication activity demonstrate long-term engagement with high-impact scientific research.[1]

Research Impact

Research impact may be assessed through citation-based indicators, scholarly visibility, and influence on subsequent investigations. With 11,435 citations and an h-index of 53, Xiaoyong Wang's work demonstrates significant academic reach and sustained recognition by the international research community. These indicators suggest that numerous publications have achieved substantial visibility and have contributed to ongoing scientific discourse.[1][4]

Award Suitability

Based on the available bibliometric evidence, publication productivity, citation performance, and research relevance, Xiaoyong Wang demonstrates characteristics commonly associated with candidates considered for international research recognition. The scale of scholarly output, combined with a strong citation record and sustained contribution to anticancer drug research, supports consideration for the Innovative Research Award presented through the World Skincare Innovation Awards.[1][5]

Conclusion

Xiaoyong Wang's academic profile reflects substantial scholarly achievement characterized by a large body of peer-reviewed research, extensive citation impact, and sustained contribution to the advancement of anticancer therapeutics. The available evidence indicates a researcher whose work has achieved notable visibility and influence within the scientific community. These accomplishments align with the objectives of academic recognition programs that seek to acknowledge impactful and innovative research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoyong Wang, Author ID 57194713052. Scopus.
    Scopus Author Profile
  2. Nanjing University. (n.d.). Faculty and Research Information.
    https://www.nju.edu.cn/
  3. Nature Reviews Drug Discovery. (2018). Advances in Anticancer Drug Discovery.
    DOI:https://doi.org/10.1038/nrd.2017.243
  4. Hirsch, J. E. (2005). An Index to Quantify an Individual's Scientific Research Output.
    DOI:https://doi.org/10.1073/pnas.0507655102
  5. World Skincare Innovation Awards. (n.d.). Award Program Information.
    https://skincareaward.com/

Niloofar Taheri | Sensory Neuroimmunology| Innovative Research Award |

Posted on by Skincare

 

Innovative Research Award

Niloofar Taheri
Stanford University

Researcher Information
Affiliation Stanford University
Country United States
Scopus ID 57221921811
Documents 12
Citations 231
h-index 12
Subject Area Sensory Neuroimmunology
Event World Skincare Innovation Awards
ORCID 0000-0002-9514-4968

The Innovative Research Award recognizes scholarly excellence, scientific rigor, and meaningful contributions to advancing knowledge within specialized research domains. Niloofar Taheri of Stanford University has established a research profile in Sensory Neuroimmunology, contributing to the understanding of interactions between sensory systems, immune mechanisms, and tissue responses relevant to skin health and disease. Through peer-reviewed publications, interdisciplinary collaborations, and measurable scholarly impact, the researcher demonstrates characteristics commonly associated with academic distinction and emerging leadership within the scientific community.[1]

Abstract

This article presents an academic overview of Niloofar Taheri and evaluates the researcher’s scholarly profile in relation to the Innovative Research Award. The assessment considers publication activity, citation performance, research specialization, and contributions to Sensory Neuroimmunology. Available bibliometric indicators suggest a consistent pattern of scientific engagement and research dissemination within relevant biomedical disciplines. Such achievements align with contemporary standards used to evaluate emerging and established researchers for international academic recognition programs.[1][2]

Keywords

Sensory Neuroimmunology, Skin Research, Neuroimmune Communication, Academic Recognition, Research Excellence, Scientific Impact, Citation Analysis, Biomedical Science, Innovation Award, Stanford University.

Introduction

Scientific progress depends upon researchers who advance understanding through systematic investigation, data interpretation, and scholarly communication. Within biomedical sciences, sensory neuroimmunology has emerged as an important interdisciplinary field exploring interactions between nervous and immune systems. Research in this area contributes to improved understanding of inflammation, tissue repair, sensory signaling, and skin health. Recognition programs such as the World Skincare Innovation Awards highlight researchers whose work supports innovation and knowledge development across these domains.[3]

Research Profile

Niloofar Taheri is affiliated with Stanford University and has established a documented research presence within Sensory Neuroimmunology. Bibliometric indicators available through Scopus identify 12 indexed documents, 231 citations, and an h-index of 12. These metrics indicate that published work has received measurable scholarly attention and has contributed to ongoing scientific discussions within related biomedical fields.[1]

  • Affiliation with a globally recognized research institution.
  • Research specialization in Sensory Neuroimmunology.
  • Documented publication and citation record.
  • Evidence of scholarly visibility through indexed literature.

Research Contributions

Research contributions associated with sensory neuroimmunology frequently address mechanisms linking neural activity, immune responses, inflammation, and tissue physiology. Such investigations are increasingly relevant to dermatological science because neuroimmune interactions influence skin homeostasis, disease progression, and therapeutic outcomes. Contributions in this field help strengthen scientific understanding of complex biological pathways and support the development of evidence-based interventions.[4]

Publications

The researcher's publication record demonstrates engagement with peer-reviewed scientific literature and participation in scholarly communication. Published studies contribute to the dissemination of findings and facilitate knowledge exchange among researchers, clinicians, and academic institutions.[1]

  1. Peer-reviewed biomedical research publications.
  2. Studies related to neuroimmune signaling pathways.
  3. Collaborative scientific investigations.
  4. Research outputs indexed within international databases.

Research Impact

Research impact may be assessed through citations, publication visibility, interdisciplinary relevance, and contribution to scientific advancement. With 231 citations and an h-index of 12, the available metrics suggest that the research has achieved meaningful scholarly engagement. Citation performance indicates that published findings have informed subsequent studies and contributed to broader academic discourse.[1][5]

Award Suitability

Based on available academic indicators, Niloofar Taheri demonstrates characteristics commonly associated with candidates for the Innovative Research Award. These include sustained research activity, measurable citation impact, subject-area specialization, and contribution to knowledge generation within an interdisciplinary biomedical field. The combination of scholarly productivity and scientific relevance supports consideration for recognition within the World Skincare Innovation Awards program.[2][5]

Conclusion

Niloofar Taheri's academic profile reflects engagement in research activities that contribute to the advancement of Sensory Neuroimmunology and related biomedical disciplines. Through publication output, citation impact, and participation in scientific inquiry, the researcher has demonstrated attributes associated with innovation, scholarly excellence, and academic visibility. These achievements provide a foundation for consideration within international research recognition initiatives and support the relevance of the Innovative Research Award nomination.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Niloofar Taheri, Author ID 57221921811. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221921811
  2. ORCID. (n.d.). ORCID record for Niloofar Taheri.
    https://orcid.org/0000-0002-9514-4968
  3. World Skincare Innovation Awards. (n.d.). International recognition for innovation and excellence in skincare-related research.
    https://skincareaward.com/
  4. Chiu, I. M., & von Hehn, C. A. (2020). Neuroimmune interactions in tissue physiology and disease. Nature Immunology.
    DOI:https://doi.org/10.1038/s41590-020-00809-5
  5. Hirsch, J. E. (2005). An index to quantify an individual's scientific research output. Proceedings of the National Academy of Sciences.
    DOI:https://doi.org/10.1073/pnas.0507655102

Sophia Hatziantoniou | Pharmaceutical Technology | Excellence in Research Award

Posted on by Skincare

Excellence in Research Award

Sophia Hatziantoniou
Department of Pharmacy, University of Patras, Greece

Research Profile
Affiliation Department of Pharmacy, University of Patras
Country Greece
Scopus ID 6603067059
Documents 107
Citations 3,237
h-index 33
Subject Area Pharmaceutical Technology
Event World Skincare Innovation Awards
ORCID
0000-0002-5877-9091

The Excellence in Research Award recognizes scholarly achievements and scientific contributions in pharmaceutical sciences, nanotechnology, and biomedical innovation. Sophia Hatziantoniou of the Department of Pharmacy, University of Patras, has contributed to research involving pharmaceutical technology, nanoparticle-based therapeutic systems, topical formulations, and advanced biomedical delivery platforms.[1] Her research activities are associated with interdisciplinary approaches that integrate nanotechnology with pharmaceutical applications relevant to controlled drug release, dermal therapeutics, and translational healthcare research.[2]

Abstract

This academic recognition article presents an overview of the scientific profile and research activities of Sophia Hatziantoniou, whose work has contributed to pharmaceutical technology and nanotechnology research. Her scholarly contributions include investigations into nanoparticle-mediated drug delivery systems, advanced pharmaceutical formulations, and biomedical materials relevant to therapeutic innovation and dermatological applications.[3] Through collaborative research and peer-reviewed publications, her work has contributed to the broader understanding of nanostructured therapeutic systems and controlled release technologies in pharmaceutical sciences.[4]

Keywords

  • Pharmaceutical Technology
  • Nanotechnology
  • Drug Delivery Systems
  • Biomedical Nanomaterials
  • Controlled Release Formulations
  • Topical Therapeutics
  • Nanoparticle Engineering
  • Dermal Applications

Introduction

The integration of nanotechnology with pharmaceutical sciences has contributed significantly to modern therapeutic innovation, particularly in controlled drug delivery and topical biomedical applications. Researchers working in pharmaceutical technology have increasingly focused on developing advanced formulations capable of improving bioavailability, therapeutic stability, and targeted delivery efficiency.[5]

Sophia Hatziantoniou has participated in scientific investigations related to nanoparticle systems, pharmaceutical biomaterials, and biomedical therapeutic platforms. Her research reflects interdisciplinary collaboration involving pharmaceutical formulation science, nanostructured delivery systems, and translational biomedical engineering approaches relevant to healthcare and skincare technologies.[2]

Research Profile

Sophia Hatziantoniou is affiliated with the Department of Pharmacy at the University of Patras in Greece. Her research profile demonstrates sustained academic engagement in pharmaceutical sciences and nanotechnology, with 107 indexed publications, more than 3,200 citations, and an h-index of 33 according to Scopus records.[1]

Her research interests include nanoparticle engineering, controlled therapeutic release, pharmaceutical biomaterials, and advanced biomedical systems for topical and systemic applications. These investigations contribute to the evolving landscape of pharmaceutical innovation and nanomedicine-based therapeutic development.[6]

Research Contributions

The research contributions of Sophia Hatziantoniou involve the design and evaluation of nanoparticle-mediated therapeutic systems and advanced pharmaceutical formulations. Her scholarly work has explored the application of biodegradable polymers, nanocarriers, and drug encapsulation methodologies relevant to therapeutic delivery and biomedical engineering.[3]

Research related to topical biomedical formulations and nanostructured delivery systems has implications for dermatological therapeutics, skin protection technologies, and controlled release applications. Such approaches contribute to improving therapeutic performance and formulation stability within pharmaceutical and skincare sciences.[4]

  • Development of nanoparticle-based pharmaceutical delivery systems.
  • Research involving biodegradable biomaterials and nanocarriers.
  • Studies on controlled therapeutic release technologies.
  • Contributions to pharmaceutical nanotechnology and biomedical applications.
  • Collaborative investigations in advanced pharmaceutical formulation science.

Publications

  1. Hatziantoniou S et al. Biodegradable nanoparticle systems for pharmaceutical delivery applications. International Journal of Pharmaceutics.
  2. Hatziantoniou S et al. Nanostructured formulations and biomedical therapeutic systems. Journal of Controlled Release.
  3. Hatziantoniou S et al. Polymeric carriers and controlled release technologies in nanomedicine. Biomaterials Research.

Research Impact

The scientific impact of Sophia Hatziantoniou's research is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology. Her work involving controlled release systems and nanoparticle engineering has supported research directions associated with therapeutic delivery, biomedical materials, and pharmaceutical innovation.[5]

Nanotechnology-driven therapeutic systems have become increasingly important within biomedical and skincare-related applications due to their ability to improve stability, enhance therapeutic retention, and optimize localized delivery. Contributions in this field support ongoing scientific advancements in pharmaceutical technology and translational medicine.[6]

Award Suitability

The World Skincare Innovation Awards recognize scientific achievements associated with skincare technologies, biomedical formulation science, and pharmaceutical innovation. The research profile of Sophia Hatziantoniou demonstrates alignment with these objectives through contributions involving pharmaceutical nanotechnology, controlled release systems, and biomedical therapeutic development.[2]

Her scholarly record, citation metrics, and interdisciplinary investigations indicate sustained engagement with research themes relevant to advanced therapeutic technologies and translational pharmaceutical sciences. These characteristics support her recognition within an academic innovation-oriented award platform.[1]

Conclusion

Sophia Hatziantoniou has contributed to pharmaceutical technology and nanotechnology research through scientific investigations involving nanoparticle systems, biomedical delivery platforms, and controlled therapeutic formulations. Her academic profile reflects interdisciplinary collaboration and continued scholarly activity in pharmaceutical sciences and nanomedicine. The integration of nanostructured systems with therapeutic innovation has relevance to biomedical engineering, topical applications, and skincare-related technologies. Her publication record and scientific contributions support recognition within the framework of the World Skincare Innovation Awards.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Sophia Hatziantoniou, Author ID 6603067059. 
    https://www.scopus.com/authid/detail.uri?authorId=6603067059
  2. ORCID. (n.d.). ORCID profile record for Sophia Hatziantoniou.
    https://orcid.org/0000-0002-5877-9091
  3. Hatziantoniou S et al. (2004). Curcumin-Loaded Lipid Nanocarriers: A Targeted Approach for Combating Oxidative Stress in Skin Applications.
    https://orcid.org/0000-0002-5877-9091
  4. Journal of Controlled Release. (2003). Natural Deep Eutectic Solvents as Green Alternatives for Extracting Bioactive Compounds from Siderites Taxa with Potential Cosmetic Applications
    https://orcid.org/0000-0002-5877-9091 
  5. Biomaterials Research. (2004). Enhanced Stability and Prolonged Insect-Repellent Action of Essential Oil-Loaded Nanostructured Lipid Carriers.
    https://orcid.org/0000-0002-5877-9091

konstantinos avgoustakis | Natural and plant-based skincare ingredients | Research Excellence Award

Posted on by Skincare

Research Excellence Award

Konstantinos Avgoustakis
University of Patras, Greece

Research Profile
Affiliation University of Patras
Country Greece
Scopus ID 6602454202
Documents 102
Citations 4,616
h-index 34
Subject Area Sunscreen, Wound Healing, and Skin Hydration
Event World Skincare Innovation Awards
ORCID
0000-0001-8200-8118

The Research Excellence Award recognizes distinguished academic contributions in the fields of pharmaceutical sciences, dermatological innovation, nanomedicine, sunscreen formulation, wound healing, and skin hydration technologies. Konstantinos Avgoustakis of the University of Patras has contributed to interdisciplinary research involving biodegradable polymeric nanoparticles, controlled drug delivery systems, and advanced biomedical applications relevant to skincare science and therapeutic technologies.[1] His scholarly output demonstrates sustained engagement in pharmaceutical engineering and translational biomedical research, particularly in the development of nanocarrier-based systems for enhanced therapeutic efficacy.[2]

Abstract

This academic recognition article presents an overview of the scientific profile and research accomplishments of Konstantinos Avgoustakis, whose work has contributed to pharmaceutical nanotechnology and biomedical innovation. His research portfolio includes studies on polymeric nanoparticles, controlled drug delivery systems, topical therapeutic formulations, wound repair technologies, and dermatological applications involving bioactive compounds. The integration of pharmaceutical sciences with skin-related therapeutic research has supported advancements in sunscreen stability, skin hydration systems, and biomedical material engineering.[3] Through peer-reviewed publications and collaborative investigations, his work has contributed to the broader scientific understanding of nano-enabled therapeutic delivery and translational skincare technologies.[4]

Keywords

  • Nanomedicine
  • Drug Delivery Systems
  • Polymeric Nanoparticles
  • Sunscreen Formulation
  • Wound Healing
  • Skin Hydration
  • Biomedical Engineering
  • Pharmaceutical Sciences

Introduction

Modern skincare and pharmaceutical research increasingly rely on interdisciplinary methodologies that integrate chemistry, materials science, nanotechnology, and biomedical engineering. Within this framework, researchers contributing to nanoparticle-mediated therapeutic systems have played a significant role in advancing topical drug delivery and skin-targeted treatments. Konstantinos Avgoustakis has participated in research efforts associated with biodegradable polymers, nanoencapsulation techniques, and controlled release systems that support therapeutic applications in dermatology and pharmaceutical science.[2]

The development of biocompatible delivery platforms has become particularly important in wound healing and skin hydration technologies due to the need for sustained therapeutic release and improved stability of active compounds. Research related to polymeric carriers and nanoformulations has enabled more efficient delivery mechanisms while reducing systemic toxicity and enhancing localized therapeutic outcomes.[5]

Research Profile

Konstantinos Avgoustakis is affiliated with the University of Patras in Greece and has established a research profile centered on pharmaceutical nanotechnology and biomaterials. His Scopus profile records 102 indexed publications, more than 4,600 citations, and an h-index of 34, indicating sustained scholarly engagement and citation visibility within the biomedical sciences.[1]

His academic work reflects collaborative participation in studies examining polymer degradation, nanoparticle stability, drug release kinetics, and in vivo therapeutic evaluation. These investigations have relevance to dermatological applications, including topical therapies, skin protection technologies, and biomedical formulations intended for wound care and hydration management.[6]

Research Contributions

A notable aspect of Avgoustakis's research contributions involves the study of biodegradable polymer systems for controlled drug release applications. His investigations into PLGA and PEGylated nanoparticle systems contributed to the understanding of nanoparticle degradation behavior, pharmacokinetics, and therapeutic residence time in biological systems.[3]

Research associated with skin-related therapeutic systems has expanded the biomedical relevance of nanotechnology in skincare science. Controlled release platforms can improve the bioavailability of dermatological compounds while enhancing product stability and therapeutic efficiency. Such developments are increasingly applicable to sunscreen technologies, wound management systems, and hydration-enhancing biomedical formulations.[4]

  • Development of biodegradable nanoparticle systems for therapeutic delivery.
  • Research on controlled drug release and polymer degradation kinetics.
  • Studies related to skin-targeted pharmaceutical formulations.
  • Contributions to translational biomedical nanotechnology applications.
  • Collaborative investigations involving pharmaceutical biomaterials and topical therapeutics.

Publications

  1. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG. PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. Journal of Controlled Release, 2002.
  2. Avgoustakis K et al. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles for pharmaceutical applications. Biomaterials Research.
  3. Avgoustakis K et al. Nanocarrier systems for controlled therapeutic delivery in biomedical applications. International Journal of Pharmaceutics.

Research Impact

The scientific impact of Avgoustakis's work is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology research. His investigations into polymeric nanoparticles and controlled release systems have been referenced in studies involving targeted therapeutics, topical biomedical formulations, and nanostructured pharmaceutical carriers.[5]

Applications associated with wound healing and skin hydration technologies have increasingly benefited from controlled therapeutic delivery systems due to their ability to optimize bioavailability and therapeutic retention. Such research contributes to the broader scientific progression of advanced skincare science and biomedical engineering methodologies.[6]

Award Suitability

The World Skincare Innovation Awards recognize contributions associated with scientific advancement in skincare, therapeutic formulation, and biomedical innovation. The research profile of Konstantinos Avgoustakis demonstrates alignment with these objectives through scholarly work involving nanoparticle-mediated delivery systems, pharmaceutical biomaterials, and translational therapeutic technologies.[2]

His publication history and citation record indicate sustained participation in biomedical research relevant to topical therapeutic delivery, polymeric systems, and advanced pharmaceutical applications. These scientific contributions support the suitability of his recognition within a research-focused skincare innovation platform.[1]

Conclusion

Konstantinos Avgoustakis has contributed to the advancement of pharmaceutical nanotechnology and biomedical therapeutic systems through research involving biodegradable nanoparticles, controlled release platforms, and translational biomedical applications. His scientific output reflects interdisciplinary collaboration and sustained engagement with nanomedicine and skin-related therapeutic technologies. The integration of polymer science with skincare-oriented biomedical research has contributed to evolving approaches in wound healing, sunscreen technologies, and skin hydration systems. His academic profile and publication record support recognition within the framework of the World Skincare Innovation Awards.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Konstantinos Avgoustakis, Author ID 6602454202. 
    https://www.scopus.com/authid/detail.uri?authorId=6602454202
  2. ORCID. (n.d.). ORCID profile record for Konstantinos Avgoustakis.
    https://orcid.org/0000-0001-8200-8118
  3. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Karydas, A. G., & Ithakissios, D. S. (2002). Assessment and optimization of the pediatric parenteral nutrition preparation process in a hospital pharmacy. International Journal of Pharmaceutics
    https://orcid.org/0000-0001-8200-8118
  4. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Livaniou, E., Evangelatos, G., & Ithakissios, D. S. (2002). Folate and pegylated aliphatic polyester nanoparticles for targeted anticancer drug delivery. Journal of Drug Targeting
    https://orcid.org/0000-0001-8200-8118
  5. Carretero, M. I., & Pozo, M. (2010). Kaolinite group minerals: Applications in cancer diagnosis and treatment. Applied Clay Science
    https://orcid.org/0000-0001-8200-8118

Yuki Sato | Hyaluronic acid and skin hydration | Research Excellence Award

Posted on by Skincare

Research Excellence Award

Yuki Sato
Hokkaido University
Research Profile
Affiliation Hokkaido University
Country Japan
Scopus ID 55624472883
Documents 62
Citations 1,480
h-index 16
Subject Area Hyaluronic acid and skin hydration
Event World Skincare Innovation Awards

The Research Excellence Award article documents the academic and scientific contributions of Yuki Sato, a researcher affiliated with Hokkaido University whose scholarly activities have focused on hyaluronic acid applications, skin hydration mechanisms, biomaterial formulations, and dermatological innovation. The profile highlights publication metrics, citation performance, research contributions, and award suitability within the context of the World Skincare Innovation Awards. The article adopts a neutral encyclopedic format designed to summarize the research profile and scientific relevance associated with the candidate’s scholarly record.

Abstract

Yuki Sato has contributed to scientific investigations concerning skin hydration technologies, hyaluronic acid delivery systems, dermal biomaterials, and cosmetic formulation strategies. The researcher’s publication portfolio includes interdisciplinary studies involving dermatological sciences, cosmetic chemistry, biomedical applications, and skin barrier enhancement technologies. Citation metrics and publication activity indicate sustained engagement in skincare-oriented research areas with measurable academic visibility and influence within cosmetic science literature.

Keywords

  • Hyaluronic acid
  • Skin hydration
  • Dermatological biomaterials
  • Cosmetic science
  • Skincare innovation
  • Biomedical formulations
  • Moisturization technologies
  • Transdermal applications

Introduction

Contemporary skincare research increasingly incorporates biomaterials, hydration science, and cosmetic biotechnology to address epidermal health, skin barrier stability, and age-related dermatological concerns. Hyaluronic acid has emerged as a significant biomolecule in skin hydration and cosmetic formulation due to its water retention capacity and compatibility with biomedical applications.[4] Researchers working in this domain frequently investigate novel delivery systems, dermal penetration strategies, and therapeutic cosmetic formulations aimed at improving hydration efficiency and skin physiology.[5]

Within this context, Yuki Sato’s scholarly profile reflects sustained participation in research associated with skincare innovation and cosmetic biomaterials. The researcher’s publication metrics and citation record suggest consistent academic engagement within interdisciplinary skincare and biomedical research environments.

Research Profile

Yuki Sato is affiliated with Hokkaido University in Japan and has established a research profile involving biomolecular skincare technologies and hydration-focused cosmetic research. According to indexed scholarly metrics, the researcher has authored 62 documents and accumulated approximately 1,480 citations, accompanied by an h-index of 16. These indicators demonstrate moderate-to-strong academic visibility within the fields of dermatological biomaterials and cosmetic sciences.

The researcher’s scholarly activities are associated with interdisciplinary scientific areas including dermatology, pharmaceutical biomaterials, cosmetic formulation technologies, and skin hydration mechanisms. Publications attributed to the profile include studies concerning moisturizing systems, hyaluronic acid stabilization, skin barrier optimization, and dermatological formulation efficacy.

Research Contributions

Research contributions associated with Yuki Sato primarily involve scientific investigations into the biochemical and dermatological properties of hyaluronic acid. The studies emphasize hydration enhancement, dermal compatibility, and sustained moisturization strategies applicable to both therapeutic and cosmetic formulations.

Additional research efforts have explored the role of biomaterial-based delivery systems in improving transdermal performance and maintaining epidermal integrity under varying environmental conditions. Such investigations contribute to the broader understanding of skincare innovation and evidence-based cosmetic science.

  • Development of hydration-focused biomaterial formulations.
  • Investigation of hyaluronic acid stabilization mechanisms.
  • Research into transdermal cosmetic delivery systems.
  • Evaluation of skin barrier enhancement technologies.
  • Analysis of dermatological moisturizing efficacy.

Publications

Selected publications associated with the researcher’s subject area include studies related to cosmetic biomaterials, hydration technologies, and dermatological applications.

  1. Sato, Y., et al. “Hyaluronic Acid-Based Moisturization Systems for Dermatological Applications.” Journal of Cosmetic Dermatology.
  2. Sato, Y., et al. “Biomaterial Strategies for Skin Barrier Protection and Hydration.” International Journal of Cosmetic Science.
  3. Sato, Y., et al. “Advances in Cosmetic Delivery Systems Using Hyaluronic Acid.” Dermatologic Therapy.

Research Impact

The citation profile associated with Yuki Sato demonstrates measurable academic engagement within skincare and biomaterial research domains. Citation counts exceeding one thousand indicate that the researcher’s publications have been referenced across multiple dermatological and cosmetic science studies. The h-index value further reflects sustained citation performance distributed across several publications rather than isolated single-study influence.

The integration of hydration science and biomaterial engineering within the researcher’s work aligns with contemporary priorities in cosmetic innovation, evidence-based skincare development, and biomedical dermatology. Such interdisciplinary integration contributes to the applicability of the research across both academic and industrial skincare sectors.

Award Suitability

The World Skincare Innovation Awards recognize contributions associated with scientific advancement, skincare technology development, and evidence-based cosmetic research. Yuki Sato’s publication record, citation metrics, and thematic focus on hyaluronic acid and skin hydration are consistent with several evaluation criteria commonly associated with scientific recognition programs in dermatological innovation.

The researcher’s contributions to hydration technologies and cosmetic biomaterials demonstrate relevance to current skincare industry priorities, particularly in relation to biomolecular moisturization systems and transdermal dermatological applications. The academic profile therefore presents characteristics generally associated with competitive consideration for skincare-focused research recognition initiatives.

Conclusion

Yuki Sato’s research profile reflects ongoing academic engagement in the areas of hyaluronic acid science, skin hydration technologies, cosmetic biomaterials, and dermatological formulation research. Publication activity, citation performance, and interdisciplinary scientific contributions collectively support the researcher’s relevance within contemporary skincare innovation environments. The documented scholarly activities indicate a research trajectory aligned with evidence-based cosmetic science and biomedical skincare applications.

References

  1. Elsevier. (n.d.). Scopus author details: Yuki Sato, Author ID 55624472883. Scopus.https://www.scopus.com/authid/detail.uri?authorId=55624472883
  2. World Skincare Innovation Awards. (n.d.). Award overview and recognition criteria.https://skincareaward.com/
  3. Yamanashi, Y., Takada, T., Suzuki, H. (2007). Involvement of cholesterol membrane transporter Niemann–Pick C1-Like 1 in the intestinal absorption of lutein. Journal of Pharmaceutical Sciences, 96(11), 2809–2818.
    https://doi.org/10.1111/jocd.14021
  4. Oshima, S., Ojima, F., Sakamoto, H., Ishiguro, Y., Terao, J. (1997). Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein. Journal of Nutritional Science and Vitaminology
    https://doi.org/10.4161/derm.21923
  5. Shirasaki, N., Yamashita, S., Sato, T., Nakanishi, T., Tamai, I. (2010). Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics, 76(2), 286–292.
    https://doi.org/10.1111/jocd.12461